BioStem Technologies, Inc. (OTCMKTS:BSEM) Sees Large Drop in Short Interest

BioStem Technologies, Inc. (OTCMKTS:BSEM) saw a significant drop in short interest in March. As of March 15th, there was short interest totalling 141,300 shares, a drop of 32.2% from the February 28th total of 208,400 shares. Approximately 0.8% of the shares of the company are short sold. Based on an average trading volume of 87,900 shares, the days-to-cover ratio is currently 1.6 days.

BioStem Technologies Price Performance

BSEM opened at $8.60 on Tuesday. The firm has a fifty day moving average price of $13.23 and a 200 day moving average price of $13.86. BioStem Technologies has a 1 year low of $6.77 and a 1 year high of $28.26. The stock has a market cap of $143.65 million, a P/E ratio of 12.65 and a beta of -0.39.

About BioStem Technologies

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.